Filed: 2/14/2024ACC: 0001892688-24-000038
📋 What this filing means
DARWIN GLOBAL MANAGEMENT, LTD. filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $509.48M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$509.48M
Total AUM (reported)
24.27M
Total Shares
Allocation by class
COM$396.63M77.8%
CLASS A ORD$62.76M12.3%
COM NEW$50.09M9.8%
Portfolio Concentration
Top 3$369.52M72.5%
4–10$139.96M27.5%
Top 3 weight
72.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.27M
Sole
Full voting authority
24.27M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
AMBRX BIOPHARMA INC
SOLEShares16.69M
TypeSH
Market value$237.65M
46.64%
Sole
16.69M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares4.05M
TypeSH
Market value$69.12M
13.57%
Sole
4.05M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares1.04M
TypeSH
Market value$62.76M
12.32%
Sole
1.04M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares600K
TypeSH
Market value$50.09M
9.83%
Sole
600K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares1.06M
TypeSH
Market value$42.16M
8.28%
Sole
1.06M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares579.96K
TypeSH
Market value$36.42M
7.15%
Sole
579.96K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares192.73K
TypeSH
Market value$7.03M
1.38%
Sole
192.73K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares57.70K
TypeSH
Market value$4.25M
0.83%
Sole
57.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMBRX BIOPHARMA INCSOLE | COM | 16.69M | SH | $237.65M 46.64% | 16.69M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 4.05M | SH | $69.12M 13.57% | 4.05M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 1.04M | SH | $62.76M 12.32% | 1.04M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 600K | SH | $50.09M 9.83% | 600K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 1.06M | SH | $42.16M 8.28% | 1.06M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 579.96K | SH | $36.42M 7.15% | 579.96K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 192.73K | SH | $7.03M 1.38% | 192.73K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 57.70K | SH | $4.25M 0.83% | 57.70K | 0.00 | 0.00 |